Intratumoral Ral-binding Protein 1 (RalBP1) Expression as a potential Predictor of the Efficacy of Bevacizumab Therapy in Female Patients with Ovarian Cancer

被引：0
|
作者：
Schramm, C. [1 ]
Kraus, F. [1 ]
Mayr, D. [2 ]
Chelariu-Raicu, A. [1 ]
Reichenbach, J. [1 ]
Topalov, N. E. [1 ]
Tauber, C. [1 ]
Burges, A. [1 ]
Kessler, M. [1 ]
Mahner, S. [1 ]
Trillsch, F. [1 ]
Czogalla, B. [1 ]
机构：
[1] LMU Munchen, Klin & Poliklin Frauenheilkunde & Geburtshilfe, Munich, Germany
[2] LMU Munchen, Pathol Inst, Munich, Germany
来源：
GEBURTSHILFE UND FRAUENHEILKUNDE | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1055/s-0044-1787409
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
P10
引用
收藏
页码：E42 / E42
页数：1
相关论文
共 50 条
  • [11] OGG1 rs1052133 is a potential predictor of cisplatin resistance in ovarian cancer patients
    Filina, J.
    Sagdeeva, A.
    Shamsutdinova, Y.
    Galimova, R.
    Sabirov, A.
    Halilova, A.
    Sharafetdinova, L.
    Boulygina, E.
    Rizvanov, A.
    Miftakhova, R.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2022, 52
  • [12] BRCA1 protein expression as a predictor of outcome following chemotherapy in sporadic epithelial ovarian cancer (EOC)
    Carser, J. E.
    Quinn, J. E.
    Michie, C. O.
    McCluggage, W. G.
    Williams, A. R.
    Mullan, P. B.
    Gourley, C. M.
    Harkin, D. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [13] NIRVANA-1: maintenance therapy with niraparib versus niraparib-bevacizumab in patients with advanced ovarian cancer
    Sghaier, Syrine
    Corbaux, Pauline
    Ray-Coquard, Isabelle
    Lim, Myong Cheol
    Hasegawa, Kosei
    Van Nieuwenhuysen, Els
    Gonzalez, Antonio
    Raspagliesi, Francesco
    Freyer, Gilles
    FUTURE ONCOLOGY, 2023, 19 (25) : 1715 - 1727
  • [14] Loss of cellular retinol-binding protein 1 gene expression in microdissected human ovarian cancer
    Cvetkovic, D
    Williams, SJ
    Hamilton, TC
    CLINICAL CANCER RESEARCH, 2003, 9 (03) : 1013 - 1020
  • [15] Expression of Y-Box-binding protein 1 in Chinese patients with breast cancer
    Xie, Wenxiu
    Yang, Junlan
    Cao, Yuean
    Peng, Chaosheng
    Ning, Haoyong
    Zhang, Fan
    You, Junhao
    TUMOR BIOLOGY, 2012, 33 (01) : 63 - 71
  • [16] Selenium-binding protein 1 expression in ovaries and ovarian tumors in the laying hen, a spontaneous model of human ovarian cancer
    Stammer, Karen
    Edassery, Seby L.
    Barua, Animesh
    Bitterman, Pincas
    Bahr, Janice M.
    Hales, Dale Buchanan
    Luborsky, Judith L.
    GYNECOLOGIC ONCOLOGY, 2008, 109 (01) : 115 - 121
  • [17] Significance of hyaluronan binding protein (HABP1/P32/gC1qR) expression in advanced serous ovarian cancer patients
    Yu, Ge
    Wang, Jing
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2013, 94 (01) : 210 - 215
  • [18] Eukaryotic Initiation Factor 4E-Binding Protein 1 (4EBP1) is an Independent Predictor of Poor Outcome in Ovarian Cancer
    Alabdullah, M. L.
    Miligy, I.
    Moseley, P.
    Madhusudan, S.
    Chan, S.
    Rakha, E.
    JOURNAL OF PATHOLOGY, 2018, 245 : S14 - S14
  • [19] Expression of the plasminogen activator inhibitor-1 RNA binding protein (PAI-RBP1) in epithelial ovarian cancer (OC).
    Koensgen, D
    Jalid, S
    Mustea, A
    Dahl, E
    Klaman, I
    Petschke, B
    Sun, P
    Lichtenegger, W
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 868S - 868S
  • [20] Intratumoral IGF-1 protein expression is selectively up-regulated in breast cancer patients with BRCA1/2 mutations.
    Hudelist, G.
    Wagner, T.
    Fink-Retter, A.
    Gschwantler-Kaulich, D.
    Czerwenka, K.
    Kroiss, R.
    Muy-Kheng, T.
    Pischinger, K.
    Koestler, W.
    Attems, J.
    Mueller, R.
    Blaukopf, C.
    Kubista, E.
    Singer, C.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S210 - S210
12345